Provided by Tiger Trade Technology Pte. Ltd.

Beyond Air, Inc.

0.6723
-0.0500-6.92%
Pre-market: 0.6572-0.0151-2.25%04:01 EDT
Volume:140.37K
Turnover:97.52K
Market Cap:7.08M
PE:-0.13
High:0.7200
Open:0.7200
Low:0.6710
Close:0.7223
52wk High:5.84
52wk Low:0.6666
Shares:10.53M
Float Shares:9.16M
Volume Ratio:1.18
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0645
EPS(LYR):-13.7727
ROE:-240.21%
ROA:-51.20%
PB:0.87
PE(LYR):-0.05

Loading ...

Beyond Air Q3 EPS $(0.85) Misses $(0.74) Estimate, Sales $2.194M Beat $2.146M Estimate

Benzinga
·
Feb 13

Beyond Air Inc. Q3 revenue doubles to USD 2.2 million

Reuters
·
Feb 13

Beyond Air Inc: Maintain Fiscal Year 2026 Revenue Guidance of $8-10 Mln

THOMSON REUTERS
·
Feb 13

Analysts’ Top Healthcare Picks: Beyond Air (XAIR), Molina Healthcare (MOH)

TIPRANKS
·
Feb 06

Beyond Air-Tochter Beyond Cancer präsentiert Phase-1-Daten zu UNO-Therapie auf AACR 2026

Reuters
·
Feb 04

Beyond Air files to sell 7.86M shares of common stock for holders

TIPRANKS
·
Jan 31

XTL Biopharmaceuticals Moves to Acquire 85% Stake in NeuroNOS Ltd

Reuters
·
Jan 30

Beyond Air CEO to Present at Virtual Healthcare Investor Conferences

Reuters
·
Jan 28

Beyond Air Inc. to Announce Third Fiscal Quarter 2026 Financial Results via Conference Call and Webcast

Reuters
·
Jan 27

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 21

Beyond Air initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
Jan 20

XTL Biopharmaceuticals Acquires 85% Stake in Beyond Air’s NeuroNOS Subsidiary

Reuters
·
Jan 15

Beyond Air Raises $5 Million in Private Placement of Common Stock and Warrants

Reuters
·
Jan 14

Press Release: Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dow Jones
·
Jan 14

Crude Oil Rises Sharply; US Inflation Rate Holds Steady At 2.7%

Benzinga
·
Jan 14

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR)

TIPRANKS
·
Jan 13

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire
·
Jan 13

XTL Biopharmaceuticals to Acquire NeuroNOS from Beyond Air

Reuters
·
Jan 13

X T L Biopharmaceuticals Ltd: Beyond Air to Receive up to $32.5 Mln in Upfront, Development and Commercial Milestone Payments

THOMSON REUTERS
·
Jan 13

X T L Biopharmaceuticals Ltd: Neuronos Will NOW Serve as Xtl's Flagship Platform for Autism and Neuro-Oncology Therapeutics

THOMSON REUTERS
·
Jan 13